Milind Deshpande Insider Trading $ACHN ACHILLION PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Milind Deshpande.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Milind Deshpande. Milind Deshpande is Chief Executive Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and EVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and Pres R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President and CEO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and President of R&D and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and SVP and CSO in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in Spero Therapeutics, Inc. ($SPRO).

Milind Deshpande in ACHILLION PHARMACEUTICALS INC

Trading Symbol: ACHN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Milind Deshpande: Chief Executive Officer, President and CEO, President and CSO, Pres R&D and CSO, President of R&D and CSO, EVP and CSO, SVP and CSO
Holdings: 2,500 shares
Current Value: $10,950
Latest Transaction: Feb 13 2018
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Milind Deshpande in ACHILLION PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACHN, SPRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 13 2018ACHNACHILLION PHARMACE ...Deshpande MilindChief Executive Off ...Option ExerciseA2.90640,0001,856,000640,000
Jan 19 2017ACHNACHILLION PHARMACE ...Deshpande MilindChief Executive Off ...Option ExerciseA4.11458,0001,882,380458,000
Dec 05 2016ACHNACHILLION PHARMACE ...Deshpande MilindChief Executive Off ...BuyP4.062,50010,1502,5000 to 2.5 K
Jan 22 2016ACHNACHILLION PHARMACE ...Deshpande MilindChief Executive Off ...Option ExerciseA7.61400,0003,044,000400,000
Jan 23 2015ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseM3.02100,000302,000300,000
Jan 23 2015ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOSellS15.00100,0001,500,0000100 K to 0 (-100.00 %)
Jan 23 2015ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOBuyM3.02100,000302,000100,0000 to 100 K
Dec 04 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseA13.24345,0004,567,800345,000
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseM3.10124,424385,71475,576
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseM3.2860,000196,8000
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseM1.0515,95016,7480
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseM4.0016,25065,0000
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOSellS10.00124,4241,244,2400124.4 K to 0 (-100.00 %)
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOBuyM3.10124,424385,714124,4240 to 124.4 K
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOSellS10.0060,000600,000060 K to 0 (-100.00 %)
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOBuyM3.2860,000196,80060,0000 to 60 K
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOSellS10.0015,950159,500016 K to 0 (-100.00 %)
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOBuyM1.0515,95016,74815,9500 to 16 K
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOSellS10.0016,250162,500016.3 K to 0 (-100.00 %)
Aug 19 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOBuyM4.0016,25065,00016,2500 to 16.3 K
May 23 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseA3.02250,000755,000400,000
May 23 2014ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseJ3.02250,000755,000150,000
Dec 19 2013ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseA3.02400,0001,208,000400,000
May 30 2013ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CEOOption ExerciseA7.59600,0004,554,000600,000
Dec 20 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident of R&D an ...Option ExerciseA8.64145,0001,252,800145,000
Mar 19 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.055,3125,57815,950
Mar 19 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS10.705,31256,83805.3 K to 0 (-100.00 %)
Mar 19 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.055,3125,5785,3120 to 5.3 K
Jan 11 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.0510,62511,15621,262
Jan 11 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS9.3410,62599,238010.6 K to 0 (-100.00 %)
Jan 11 2012ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.0510,62511,15610,6250 to 10.6 K
Dec 14 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident of R&D an ...Option ExerciseA7.59100,000759,000100,000
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.055,3135,57931,887
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.6013,12521,0000
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.6018,75030,0000
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOOption ExerciseM1.6012,50020,0000
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS8.505,31345,16105.3 K to 0 (-100.00 %)
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS8.0544,375357,3795,31349.7 K to 5.3 K (-89.31 %)
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.055,3135,57949,68844.4 K to 49.7 K (+11.97 %)
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.6013,12521,00044,37531.3 K to 44.4 K (+42.00 %)
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.6018,75030,00031,25012.5 K to 31.3 K (+150.00 %)
Jun 30 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOBuyM1.6012,50020,00012,5000 to 12.5 K
Jun 24 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS7.504,82536,20404.8 K to 0 (-100.00 %)
Jun 24 2011ACHNACHILLION PHARMACE ...Deshpande MilindPresident and CSOSellS7.5110,80081,0684,82515.6 K to 4.8 K (-69.12 %)
May 31 2011ACHNACHILLION PHARMACE ...Deshpande MilindPres R&D and CSOOption ExerciseM1.0547,80050,19037,200
May 31 2011ACHNACHILLION PHARMACE ...Deshpande MilindPres R&D and CSOSellS7.0147,800335,26915,62563.4 K to 15.6 K (-75.36 %)
May 31 2011ACHNACHILLION PHARMACE ...Deshpande MilindPres R&D and CSOBuyM1.0547,80050,19063,42515.6 K to 63.4 K (+305.92 %)
Dec 20 2010ACHNACHILLION PHARMACE ...Deshpande MilindPresident of R&D an ...Option ExerciseA3.10200,000620,000200,000
Dec 22 2009ACHNACHILLION PHARMACE ...Deshpande MilindEVP and CSOOption ExerciseA3.2860,000196,80060,000
Dec 17 2008ACHNACHILLION PHARMACE ...Deshpande MilindEVP and CSOOption ExerciseA1.0585,00089,25085,000
Dec 18 2007ACHNACHILLION PHARMACE ...Deshpande MilindEVP and CSOOption ExerciseA4.8260,000289,20060,000
Jun 08 2007ACHNACHILLION PHARMACE ...Deshpande MilindEVP and CSOOption ExerciseA5.4147,900259,13947,900
Dec 26 2006ACHNACHILLION PHARMACE ...Deshpande MilindSVP and CSOOption ExerciseA14.7546,000678,50046,000

Page:   1

Contact us | Follow us on Twitter